{
  "resourceType" : "PlanDefinition",
  "id" : "RecCollectionProphAnticoagulationHospitalizedCOVID19Patients",
  "meta" : {
    "profile" : ["https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/recommendation"]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: PlanDefinition RecCollectionProphAnticoagulationHospitalizedCOVID19Patients</b></p><a name=\"RecCollectionProphAnticoagulationHospitalizedCOVID19Patients\"> </a><a name=\"hcRecCollectionProphAnticoagulationHospitalizedCOVID19Patients\"> </a><a name=\"RecCollectionProphAnticoagulationHospitalizedCOVID19Patients-en-US\"> </a><p><b>url</b>: <a href=\"PlanDefinition-RecCollectionProphAnticoagulationHospitalizedCOVID19Patients.html\">PlanDefinition Prophylactic anticoagulation in hospitalized COVID-19 patients</a></p><p><b>version</b>: 1.0</p><p><b>name</b>: 15 - Prophylactic Anticoagulation</p><p><b>title</b>: Prophylactic anticoagulation in hospitalized COVID-19 patients</p><p><b>type</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/plan-definition-type workflow-definition}\">Workflow Definition</span></p><p><b>status</b>: Active</p><p><b>experimental</b>: true</p><p><b>date</b>: 2022-02-14</p><p><b>publisher</b>: Deutsche Gesellschaft für Internistische Intensivmedizin und Notfallmedizin e.V. (DGIIN)</p><p><b>description</b>: </p><div><p>Hospitalisierte Patienten mit COVID-19 sollen in Abwesenheit von Kontraindikationen eine standardmäßige medikamentöse Thromboembolieprophylaxe mit niedermolekularem Heparin erhalten. Alternativ kann Fondaparinux zur Anwendung kommen.</p>\n</div><blockquote><p><b>action</b></p><p><b>title</b>: AntithromboticProphylaxisWithLWMH</p><p><b>description</b>: </p><div><p>Antithrombotic prophylaxis with LWMH in hospitalised COVID-19 patients</p>\n</div><p><b>code</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-common-process guideline-based-care}\">Guideline-based Care</span></p><p><b>definition</b>: <a href=\"PlanDefinition-AntithrombLWMHProphInHospitalisedCOVID19PatientsRecommPlan.html\">Antithrombotic prophylaxis with LWMH in hospitalised COVID-19 patients</a></p></blockquote><blockquote><p><b>action</b></p><p><b>title</b>: AntithromboticProphylaxisWithFondaparinux</p><p><b>description</b>: </p><div><p>Antithrombotic prophylaxis with Fondaparinux</p>\n</div><p><b>code</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-common-process guideline-based-care}\">Guideline-based Care</span></p><p><b>definition</b>: <a href=\"PlanDefinition-AntithrombFondapProphInHospitalisedCOVID19PatientsRecommPlan.html\">Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients</a></p></blockquote></div>"
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability",
    "valueCode" : "computable"
  },
  {
    "url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel",
    "valueCode" : "structured"
  },
  {
    "extension" : [{
      "url" : "method",
      "valueCodeableConcept" : {
        "coding" : [{
          "system" : "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-action-combination-method",
          "code" : "exactly"
        }]
      }
    },
    {
      "url" : "threshold",
      "valuePositiveInt" : 1
    }],
    "url" : "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/ext-action-combination-method"
  }],
  "url" : "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommendation/prophylactic-anticoagulation",
  "version" : "1.0",
  "name" : "15 - Prophylactic Anticoagulation",
  "title" : "Prophylactic anticoagulation in hospitalized COVID-19 patients",
  "type" : {
    "coding" : [{
      "system" : "http://terminology.hl7.org/CodeSystem/plan-definition-type",
      "code" : "workflow-definition"
    }]
  },
  "status" : "active",
  "experimental" : true,
  "date" : "2022-02-14",
  "publisher" : "Deutsche Gesellschaft für Internistische Intensivmedizin und Notfallmedizin e.V. (DGIIN)",
  "description" : "Hospitalisierte Patienten mit COVID-19 sollen in Abwesenheit von Kontraindikationen eine standardmäßige medikamentöse Thromboembolieprophylaxe mit niedermolekularem Heparin erhalten. Alternativ kann Fondaparinux zur Anwendung kommen.",
  "action" : [{
    "title" : "AntithromboticProphylaxisWithLWMH",
    "description" : "Antithrombotic prophylaxis with LWMH in hospitalised COVID-19 patients",
    "code" : {
      "coding" : [{
        "system" : "http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-common-process",
        "code" : "guideline-based-care"
      }]
    },
    "definitionCanonical" : "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/intervention-plan/antithrombotic-prophylaxis-LMWH"
  },
  {
    "title" : "AntithromboticProphylaxisWithFondaparinux",
    "description" : "Antithrombotic prophylaxis with Fondaparinux",
    "code" : {
      "coding" : [{
        "system" : "http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-common-process",
        "code" : "guideline-based-care"
      }]
    },
    "definitionCanonical" : "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/intervention-plan/antithrombotic-prophylaxis-fondaparinux"
  }]
}